Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Myopia > Switching myopia-control spectacles may temporarily slow progression in some children
  • Myopia

Switching myopia-control spectacles may temporarily slow progression in some children

Ophthalmology 360

Key Takeaways

  1. Children who switched to a different myopia-control spectacle type showed a significant reduction in myopia progression after the change.
  2. Before switching, the change-of-type group experienced faster myopia progression than children who continued using the same spectacle type.
  3. The benefit of switching was not sustained, as myopia progression accelerated again with prolonged use of the new spectacles.

Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a study.

The retrospective matched-cohort study 1,012 children and adolescents prescribed myopia-control spectacles. Researchers compared 253 participants who switched to a different spectacle type with 759 who continued using the same type after propensity score matching.

Before the switch, children in the change-of-type group had significantly faster myopia progression than those who maintained the same spectacle type. After switching, the progression rate in the change-of-type group slowed significantly, reducing the difference in progression rates between the groups.

However, the benefit was not maintained over time. Researchers found that myopia progression accelerated again during prolonged use of the new spectacle type, with progression rates worsening in the later phase compared with the early phase after switching.

Reference

Zhang J, Pan Q, Jin L, et al. Can switching between different types of myopia control spectacles enhance effectiveness? Findings from a real-world study. Br J Ophthalmol. 2026;bjo-2025-329403. doi: 10.1136/bjo-2025-329403. Epub ahead of print. PMID: 42303290.

Share

Related Content

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Conference Roundup

EVO ICL surgery now FDA-approved for older patients

  • Myopia

Efficacy of low-dose atropine for myopia varies by ethnicity, analysis finds

  • Myopia

Low-dose atropine shows greatest benefit in younger children with progressive myopia in Phase 3 STAR trial

  • Myopia

Survey examines patient knowledge, attitudes, and practices related to refractive surgery

  • Glaucoma

Managing glaucoma in highly myopic eyes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon